Jin-Yuan Shin

Title: Jin-Yuan Shin: Innovator in Cancer Research

Introduction

Jin-Yuan Shin is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer research, particularly through his innovative work on transcriptional regulatory nucleic acid sequences.

Latest Patents

Jin-Yuan Shin holds 2 patents. His latest patents focus on the Collapsin response mediator protein-1 (CRMP-1) transcriptional regulatory nucleic acid sequences. This invention provides a transcription unit isolated from the upstream nucleic acid sequence of the CRMP-1 gene, which is recognized as an invasion-suppressor gene. The transcription unit contains a nucleic acid regulatory sequence that demonstrates promoter and/or regulatory activities, enhancing the expression of CRMP-1 and/or a reporter protein. Additionally, the invention includes a DNA construct containing this transcription unit, which can be transfected into a host cell. The over-expression of CRMP-1 in cancer cells has been shown to inhibit their metastasis.

Career Highlights

Jin-Yuan Shin is associated with Advpharma, Inc., where he continues to advance his research and innovations in the field of cancer treatment. His work has the potential to significantly impact therapeutic strategies for cancer patients.

Collaborations

Some of his notable coworkers include Pan-Chyr Yang and Tse-Ming Hong, who have collaborated with him on various research projects.

Conclusion

Jin-Yuan Shin's contributions to cancer research through his innovative patents highlight his role as a key inventor in the field. His work on CRMP-1 has the potential to change the landscape of cancer treatment and improve patient outcomes.